Avara Norman Pharmaceutical Services, a subsidiary of Avara Pharmaceutical Services, has acquired Astellas’s wholly owned manufacturing subsidiary Astellas Pharma Technologies (APT), located in Norman, OK.

APT employees will remain employed at the site, and the plant will continue to manufacture certain Astellas pharmaceutical products on a contract basis. Astellas will continue to source a stable supply of high-quality products from the facility under the oversight of Avara following the acquisition.

Tim Tyson, a global leader in the pharmaceutical industry, is chairman and chief executive officer of Avara Pharmaceutical Services. In his 35-plus year career, Mr. Tyson has negotiated complex multi-billion dollar mergers and acquisitions, led major turn-arounds that have fueled growth and value and, most significantly, has been instrumental in bringing more than 50 lifesaving and life improving medicines to the market.

“We are excited to have the APT organization join the Avara team and to add this significant capability to the Avara Company,” said Mr. Tyson. “We are honored to have the strategic partnership with Astellas and to manufacture key products for them. We are excited to be able to transition this Astellas center of technical excellence to a worldwide pharmaceutical services center of excellence.”